| Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action A Borah, R Paul, S Choudhury, A Choudhury, B Bhuyan, AD Talukdar, MD ... CNS neuroscience & therapeutics 19 (11), 847-853, 2013 | 130 | 2013 |
| Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress. A Choudhury*, R Paul*, S Kumar, A Giri, R Sandhir, A Borah PLoS One. 12 (2), e0171285, 2017 | 96 | 2017 |
| Deep learning based drowsiness detection and monitoring using behavioural approach P William, M Shamim, AR Yeruva, D Gangodkar, S Vashisht, ... 2022 2nd international conference on technological advancements in …, 2022 | 64 | 2022 |
| Cholesterol–A putative endogenous contributor towards Parkinson's disease R Paul, A Choudhury, A Borah Neurochemistry international 90, 125-133, 2015 | 62 | 2015 |
| Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases A Choudhury, T Sahu, PL Ramanujam, AK Banerjee, I Chakraborty, ... Neuropsychiatry (London) 8 (1), 395-424, 2018 | 42 | 2018 |
| Efficacy of Morin as a Potential Therapeutic Phytocomponent: Insights into the Mechanism of Action A Choudhury*, I Chakraborty, TS Banerjee, DR Vana, D Adapa Int J Med Res Health Sci 6 (11), 175-194, 2017 | 39 | 2017 |
| Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease A Choudhury*, R Paul*, DC Boruah, R Devi, P Bhattacharya, MD Choudhury, A Borah Neurochemistry International 108 (11), 15-26, 2017 | 34 | 2017 |
| Cholesterol in Pancreatic β-Cell Death and Dysfunction: Underlying Mechanisms and Pathological Implications R Paul, A Choudhury, S Choudhury, MK Mazumder, A Borah Pancreas 45 (3), 317-324, 2016 | 23 | 2016 |
| Diabetes mellitus types: Key genetic determinants and risk assessment DR Vana, D Adapa, VSS Prasad, A Choudhury, G Ahuja Genet Mol Res 18 (2), 27, 2019 | 20 | 2019 |
| Genetic diversity and antagonistic activity of plant growth promoting bacteria, isolated from tea-rhizosphere: a culture dependent study UK Vandana, A Chopra, A Choudhury, D Adapa, PB Mazumder Biomedical Research 29 (4), 853-864, 2018 | 18 | 2018 |
| Artificial Intelligence in Biological Data I Chakraborty, A Choudhury*, TS Banerjee J Inform Tech Softw Eng 7 (207), 2, 2017 | 17* | 2017 |
| L-DOPA treatment in MPTP-mouse model of Parkinson’s disease potentiates homocysteine accumulation in substantia nigra N Bhattacharjee, MK Mazumder, R Paul, A Choudhury, S Choudhury, A Borah Neuroscience letters 628, 225-229, 2016 | 17 | 2016 |
| Nutritional components relevant to type-2-diabetes: Dietary sources, metabolic functions and glycaemic effects P VSS, D Adapa, DR Vana, A Choudhury, J Asadullah, A Chatterjee Journal of Research in Medical and Dental Science 6 (5), 52-75, 2018 | 13 | 2018 |
| Neuroprotective natural products: clinical aspects and mode of action G Brahmachari John Wiley & Sons, 2017 | 10 | 2017 |
| CRISPR/Cas9 genome editing system in the diagnosis and treatment of cancer R Bhattacharjee, KD Purkayastha, D Adapa, A Choudhury* J RNAi Gene Silencing 13 (1), 545-551, 2017 | 10 | 2017 |
| Neuroprotective effect of ayurvedic preparations and natural products on Parkinsons disease A Choudhury, R Paul, MK Mazumder, A Chetia, Swapnali, Borah Neuroprotect Nat Prod Clin Aspect Mod Act 1, 1-3, 2017 | 9* | 2017 |
| Understanding the Role of Resveratrol in Major Neurological and Lifestyle Diseases: An Insight into Molecular Mechanisms and Druggability. A Choudhury, R Bhattacharjee, D Adapa, I Chakraborty, TS Banerjee, ... Pharmaceutical BioProcessing 6 (2), 064–083, 2018 | 5 | 2018 |
| Cognitive and psychological anomalies in parkinson’s disease: an insight into non-motor characteristic features D Adapa Neuropsychiatry (London) 7 (6), 1069-1080, 2017 | 5 | 2017 |
| Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson’s disease A Dutta, BC Phukan, R Roy, MK Mazumder, R Paul, A Choudhury, ... Metabolic Brain Disease 37 (6), 1887-1900, 2022 | 4 | 2022 |
| An update on pathological implications of enzymatic dysregulation in Alzheimer’s disease A Choudhury, I Chakraborty, R Bhattacharjee, T Subhra, DRV Banerjee, ... Biomed. Res 29, 2215-2226, 2018 | 4 | 2018 |
Rudrarup Bhattacharjee, PhDPostdoctoral Researcher, Adelaide Centre for Epigenetics, University of Adelaide, SA, Australia在 adelaide.edu.au 的电子邮件经过验证
